Exogenous ketones as a metabolic intervention for Parkinson’s disease

Exogenous ketones as a metabolic intervention for Parkinson’s disease

<p>Neurodegenerative and neurological diseases are metabolic diseases that invite metabolic treatments. Nutritional interventions that induce a state of ketosis, or “ketogenics,” are one class of metabolic treatment that have the potential to address the root pathologies of such diseases. Pr...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Norwitz, N
Rannpháirtithe:	Clarke, K
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2020
Ábhair:	Metabolism Neurodegenerative diseases

Míreanna comhchosúla

Metabolism of exogenous ketones
de réir: Stubbs, B
Foilsithe / Cruthaithe: (2016)

Insights into Lipid Metabolism and Composition in Parkinson’s Disease Pathogenesis
de réir: Pei Xiaoxue, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
de réir: Juhyun eSong, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
de réir: Ahmed Tanvir, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging
de réir: Nicholas R. W. Cleland, et al.
Foilsithe / Cruthaithe: (2021-10-01)

The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases
de réir: Majid Eslami, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Targeting cardiolipin metabolism for Parkinson's disease therapy
de réir: Junli Liu, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?
de réir: Theodora Mourtzi, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases
de réir: Ali Kishk, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
de réir: I.I. Stoyanova
Foilsithe / Cruthaithe: (2014-12-01)

Effect of a physical therapeutic intervention on locomotive syndrome in the elderly patients with Parkinson’s disease and sarcopenia
de réir: Ivanna V. Didoha, et al.
Foilsithe / Cruthaithe: (2023-03-01)

OPA1 deficiency impairs oxidative metabolism in cycling cells, underlining a translational approach for degenerative diseases
de réir: Aurélie M. C. Millet, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
de réir: Paulo J. da Costa, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism
de réir: Alessio Canovai, et al.
Foilsithe / Cruthaithe: (2025-01-01)

On the Metabolism of Exogenous Ketones in Humans
de réir: Stubbs, B, et al.
Foilsithe / Cruthaithe: (2017)

On the Metabolism of Exogenous Ketones in Humans
de réir: Brianna J. Stubbs, et al.
Foilsithe / Cruthaithe: (2017-10-01)

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
de réir: Nicholas G. Norwitz, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
de réir: Chengyong Liu, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
de réir: Chun Chen, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Exogenous ketone therapy for heart failure: A review
de réir: Yulia O. Aksenova, et al.
Foilsithe / Cruthaithe: (2023-05-01)

The role of the gut microbiota in neurodegenerative diseases targeting metabolism
de réir: Yufeng Fu, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Secretome as neuropathology-targeted intervention of Parkinson’s disease
de réir: Christian Ardianto, et al.
Foilsithe / Cruthaithe: (2022-12-01)

The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases
de réir: Jumin Xie, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Ketone metabolism in the heart
de réir: Bin abdul kadir, A
Foilsithe / Cruthaithe: (2020)

The genetic basis of Parkinson's disease
de réir: A. A. Tappakhov, et al.
Foilsithe / Cruthaithe: (2017-03-01)

The importance of using methods of selective modification of neuronal function in the pathogenesis and therapy of Parkinson's disease
de réir: Maciej Superson, et al.
Foilsithe / Cruthaithe: (2024-07-01)

No association between adult height and Parkinson's disease
de réir: Younggee Jeong, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Impact of tango on Parkinson's disease - a narrative review
de réir: Magdalena Muzyk, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
de réir: Hayder M. Al‐kuraishy, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Meaning in life and Parkinson’s disease in the UK Biobank
de réir: Angelina R. Sutin, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Alpha-Synuclein spreading in Parkinson disease
de réir: Ariadna eRecasens, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson’s, Alzheimer’s and ALS disease
de réir: Radhika Patel, et al.
Foilsithe / Cruthaithe: (2019-05-01)

OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease
de réir: Azadeh Seyedjoodaki, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
de réir: Srinivasa Reddy Bonam, et al.
Foilsithe / Cruthaithe: (2021-12-01)

The diagnostic reliability of outpatient neurological care to patients with Parkinson’s disease
de réir: Voskresenskaya O.N., et al.
Foilsithe / Cruthaithe: (2012-06-01)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
de réir: Song Li, et al.
Foilsithe / Cruthaithe: (2022-04-01)

The emerging role of disease-associated microglia in Parkinson’s disease
de réir: Ritika R. Samant, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
de réir: Madeline M. Vroom, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Anti-Oxidant and Tyrosinase Inhibitory In Vitro Activity of Amino Acids and Small Peptides: New Hints for the Multifaceted Treatment of Neurologic and Metabolic Disfunctions
de réir: Grazia Luisi, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
de réir: Berenice A. Gutierrez, et al.
Foilsithe / Cruthaithe: (2022-07-01)